AKYA(Delisted)
Akoya Biosciences·NASDAQ
--
--(--)
Signals Analysis
Bullish signal 1
Bearish signal 1
EPS Beats Expectation
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About AKYA
Akoya Biosciences, Inc.
A spatial biology company that develops biomarker and immunofluorescence tissue analysis toetter
100 Campus Drive, 6th Floor, Marlborough, Massachusetts 01752
--
Akoya Biosciences, Inc., was incorporated in Delaware on November 13, 2015. The company is an innovative life science technology company that provides spatial biology solutions focused on transformational discovery and clinical research. The company's mission is to provide a revolutionary new space-derived biomarker to enable life science researchers to better understand disease and enable clinicians to improve patient outcomes.
Company Financials
EPS
AKYA has released its 2025 Q1 earnings. EPS was reported at -0.32, versus the expected -0.23, missing expectations. The chart below visualizes how AKYA has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
AKYA has released its 2025 Q1 earnings report, with revenue of 16.64M, reflecting a YoY change of -9.32%, and net profit of -15.65M, showing a YoY change of 33.35%. The Sankey diagram below clearly presents AKYA's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
